Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB.DL)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BIB.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

iddqkfyou (57.33)
Submitted April 14, 2010

Biotech has been on a log-linear path for years now... because it is not cyclical, it is developmental, a newly developing system. This is a new fronter. We all know about Moore's Law; it will not take long before someone quantifies our gene and… More

TrackUltraLong (< 20)
Submitted September 10, 2012

http://www.fool.com/investing/general/2012/09/06/3-stocks-near-52-week-highs-worth-selling.aspx

NASDAQ:BIB.DL VS S&P 500 (SPY)

NASDAQ:BIB.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about BIB.DL.

No one has written a Pitch for BIB.DL stock yet. Tell us why you think BIB.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in BIB.DL.

No players have picked BIB.DL yet. Tell us why you think BIB.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BIB.DL.